Aqueous eye drop formulations: Cyclodextrins as enabling excipients.

Area of Science:

• Pharmaceutical Science
• Drug Delivery
• Ophthalmology

Background:

• Cyclodextrins are widely used pharmaceutical excipients known for solubilizing and stabilizing drugs in aqueous solutions.
• They exhibit favorable pharmacokinetic and toxicological profiles, leading to their common use in oral and parenteral medications.
• Despite their benefits, cyclodextrins are currently underutilized in ophthalmic product development.

Purpose of the Study:

• To highlight the potential of cyclodextrins for ophthalmic drug delivery.
• To discuss the physical properties of cyclodextrins relevant to topical ophthalmic formulations.
• To address the regulatory and intellectual property landscape influencing their ophthalmic application.

Main Methods:

• Review of cyclodextrin properties relevant to ophthalmic formulations.
• Analysis of existing literature on cyclodextrin applications in drug delivery.
• Examination of the current regulatory and intellectual property environment for ophthalmic drugs.

Main Results:

• Cyclodextrins possess a wide range of physical properties suitable for topical ophthalmic dosage forms.
• Their established safety and efficacy in other administration routes suggest potential for ocular use.
• Favorable regulatory and intellectual property conditions now exist for ophthalmic cyclodextrin applications.

Conclusions:

• Cyclodextrins offer significant potential for enhancing ophthalmic drug delivery.
• Their unique properties and a cleared regulatory environment should encourage their adoption in new ophthalmic formulations.
• Further research and development are warranted to fully leverage cyclodextrins in ophthalmology.